- Association between antibody levels and characteristics of renal failure patients on hemodialysis.
| Variables | Mean±SD | Median (IQR) | P-values |
|---|---|---|---|
| Gender | |||
| Male | 2.26±1.15 | 3.00 (1.75-3.00) | 0.119 |
| Female | 2.08±1.18 | 2.86 (1.35-3.00) | |
| Age group (years) | |||
| <19 | 2.12±1.32 | 3.00 (0.81-3.00) | 0.990 |
| 20-40 | 2.08±1.24 | 3.00 (1.24-3.00) | |
| 41-60 | 2.21±1.09 | 3.00 (1.69-3.00) | |
| >60 | 2.09±1.21 | 3.00 (1.28-3.00) | |
| Time of diagnosis with renal failure | |||
| Before vaccine was started | 2.18±1.15 | 3.00 (1.52-3.00) | 0.772 |
| After vaccination was started | 2.04±1.21 | 3.00 (1.30-3.00) | |
| Cause of renal failure | |||
| Diabetes | 2.04±1.24 | 3.00 (0.84-3.00) | 0.623 |
| Hypertension | 2.01±1.18 | 2.56 (1.27-3.00) | |
| Hereditary/congenital | 2.14±1.09 | 3.00 (1.29-3.00) | |
| Other disease(s) | 2.37±1.11 | 3.00 (2.25-3.00) | |
| Unknown | 2.26±1.13 | 3.00 (1.88-3.00) | |
| Previous COVID-19 infection | |||
| No | 2.21±1.13 | 3.00 (1.54-3.00) | 0.182 |
| Yes | 1.86±1.30 | 2.58 (0.04-3.00) | |
| Type of vaccines received | |||
| Homogenous | 2.05±1.20 | 2.94 (1.27-3.00) | 0.178 |
| Heterogeneous | 2.31±1.10 | 3.00 (2.02-3.00) | |
| Number of doses | |||
| One | 0.04±0.02 | 0.03 (0.03-0.03) | <0.001* |
| 2 | 1.87±1.16 | 2.21 (1.20-3.00) | |
| 3 | 2.48±1.01 | 3.00 (2.37-3.00) | |
| Time since last dose | |||
| 10 weeks | 2.27±1.10 | 3.00 (1.59-3.00) | 0.063 |
| 12 weeks | 2.00±1.24 | 2.58 (0.09-3.00) | |
Values are presented as mean ± standard deviation (SD) and median and interquartile range (IQR).
↵* Significant at 95% confidence level. Data presented are obtained from Mann-Whitney and Kruskal-Wallis tests. COVID-19: coronavirus disease-19